Receptor-interacting protein kinase-3 (RIPK3): a new biomarker for necrotising enterocolitis in preterm infants
Pediatric Surgery International · 2024
DOI: 10.1007/s00383-024-05697-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Surgery International, 2024. Verfasst von Lirong Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Receptor-Interacting Protein Serine-Threonine Kinases, Biomarkers, Infant, Premature. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Project of Suzhou, the Scientific Research Project of the Jiangsu Health Committee.
Themen: Neonatologie
Abstract (Originalsprache)
Objective
This study aimed to evaluate the role of receptor-interacting protein kinase-3 ( RIPK3 ) in the diagnosis, estimation of disease severity, and prognosis of premature infants with necrotising enterocolitis (NEC).
Methods
RIPK3 , lactic acid ( LA ), and C-reactive protein ( CRP ) levels were measured in the peripheral blood of 108 premature infants between 2019 and 2023, including 24 with stage II NEC, 18 with stage III NEC and 66 controls. Diagnostic values of the indicators for NEC were evaluated via receiver operating characteristic (ROC) curve analysis.
Results
Plasma RIPK3 and LA levels upon NEC suspicion in neonates with stage III NEC were 32.37 ± 16.20 ng/mL. The ROC curve for the combination of RIPK3, LA, CRP for NEC diagnosis were 0.925. The time to full enteral feeding (FEFt) after recovery from NEC was different between two expression groups of plasma RIPK3 ( RIPK3 < 20.06 ng/mL and RIPK3 ≥ 20.06 ng/mL).
Conclusion
Plasma RIPK3 can be used as a promising marker for the diagnosis and estimation of disease severity of premature infants with NEC and for the guidance on proper feeding strategies after recovery from NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu Province, China.
- Department of Neonatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu Province, China. grgreed@163.com.
Förderung
- the Science and Technology Project of Suzhou
- the Scientific Research Project of the Jiangsu Health Committee
Zitieren
APA
Shen, L., Yang, Z., Gao, C., Li, L., Wang, Y., Cai, Y., & Feng, Z. (2024). Receptor-interacting protein kinase-3 (RIPK3): a new biomarker for necrotising enterocolitis in preterm infants. Pediatric Surgery International. https://doi.org/10.1007/s00383-024-05697-x
Vancouver
Shen L, Yang Z, Gao C, Li L, Wang Y, Cai Y, et al. Receptor-interacting protein kinase-3 (RIPK3): a new biomarker for necrotising enterocolitis in preterm infants. Pediatric Surgery International. 2024. doi:10.1007/s00383-024-05697-x
BibTeX
@article{Shen2024,
author = {Shen, Lirong and Yang, Zuming and Gao, Chuchu and Li, Lili and Wang, Yu and Cai, Yan and Feng, Zongtai},
title = {Receptor-interacting protein kinase-3 (RIPK3): a new biomarker for necrotising enterocolitis in preterm infants},
journal = {Pediatric Surgery International},
year = {2024},
doi = {10.1007/s00383-024-05697-x}
}
EUVIMED